Bangalore Antibiotics And Biologicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.48 Cr
as on 23-10-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
as on 23-10-2024
- Satisfied Charges ₹ 7.00 M
as on 23-10-2024
- Revenue 39.88%
(FY 2023)
- Profit 637.73%
(FY 2023)
- Ebitda 110.20%
(FY 2023)
- Net Worth 27.11%
(FY 2023)
- Total Assets 14.01%
(FY 2023)
About Bangalore Antibiotics And Biologicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.48 Cr.
The company currently has active open charges totaling ₹6.00 M. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Aravind Krishnan, Mohan Nedungat, Premalatha Krishnan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231KL1995PTC008647
- Company No.
008647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bangalore Antibiotics And Biologicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Nedungat  | Managing Director | 27-Dec-2021 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aravind Krishnan | Director | 25-Jul-2014 | Current |
| Premalatha Krishnan | Whole-Time Director | 25-Jul-2014 | Current |
| Gopinathan Pookkunniyil | Whole-Time Director | 03-Feb-2012 | Current |
| Jayakumar | Whole-Time Director | 03-Feb-2012 | Current |
Financial Performance of Bangalore Antibiotics And Biologicals.
Bangalore Antibiotics And Biologicals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 39.88% increase. The company also saw a substantial improvement in profitability, with a 637.73% increase in profit. The company's net worth Soared by an impressive increase of 27.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bangalore Antibiotics And Biologicals?
In 2023, Bangalore Antibiotics And Biologicals had a promoter holding of 86.82% and a public holding of 13.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Banasurasagar Hotels And Resorts India Private LimitedActive 14 years 8 monthsAravind Krishnan, Mohan Nedungat and 1 more are mutual person
Fooday Spices India Private LimitedActive 5 years 7 monthsAravind Krishnan, Mohan Nedungat and 2 more are mutual person
- Pumice Projects And Properties Private LimitedActive 14 years 9 months
Mohan Nedungat is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Federal Bank Limited Creation Date: 26 Mar 2012 | ₹6.00 M | Open |
The Federal Bank Limited Creation Date: 28 Dec 2012 | ₹1.00 M | Satisfied |
Indian Overseas Bank Creation Date: 19 May 2003 | ₹6.00 M | Satisfied |
How Many Employees Work at Bangalore Antibiotics And Biologicals?
Bangalore Antibiotics And Biologicals has a workforce of 27 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bangalore Antibiotics And Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bangalore Antibiotics And Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
